Together, these data suggest that TOX, and potentially TIM-3, CTLA-4, VISTA, TIGIT, KLRG1, TOX2, SIRT1, Ki-67, and Helios mRNA levels in CRC tumor tissues increase in advanced disease stages (Table 2), suggesting their possible roles in CRC progression. This evidence concerns the gene MKI67 and colorectal carcinoma.